Marcin Hoffmann
Investitore di Private Equity presso BIB Seed Capital Management
Profilo
Marcin Hoffmann is currently the Investment Manager & CEO at BIB Seed Capital Management since 2007.
He previously worked as a Project Manager at Instytut Bioinfobank Sp zoo from 2004 to 2011 and as a Member-Supervisory Board at Medicalgorithmics SA, Genovum Sp zoo, and Proteon Pharmaceuticals SA. Dr. Hoffmann holds an MBA from Georgia State University, a doctorate degree from Adam Mickiewicz University, and a graduate degree from the same university.
Posizioni attive di Marcin Hoffmann
Società | Posizione | Inizio |
---|---|---|
BIB Seed Capital Management
BIB Seed Capital Management Investment ManagersFinance BIB Seed Capital Management (BIB Seed Capital) is the venture capital subsidiary of Instytut Bioinfobank Sp zoo. The firm was founded in 2007, and is headquartered in Poznan, Poland. | Investitore di Private Equity | 01/02/2007 |
Precedenti posizioni note di Marcin Hoffmann
Società | Posizione | Fine |
---|---|---|
Genovum Sp zoo
Genovum Sp zoo BiotechnologyHealth Technology Genovum Sp zoo provides biological data processing services. It offers services to the frontier industries: information technology, biotechnology, and health care. Its business involves the use of bioinformatics methods to support the sequencing of genomes, development of new enzymes, and new simple organisms with medicinal properties. Genovum was founded in August 2008 and is headquartered in Warschaw, Poland | Direttore/Membro del Consiglio | 01/01/2012 |
Instytut Bioinfobank Sp zoo | Corporate Officer/Principal | 01/01/2011 |
Proteon Pharmaceuticals SA
Proteon Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Proteon Pharmaceuticals SA develops, manufactures, and sells pharmaceutical products and drugs. The firm offers Bafasal and Bafador. Its services include Veterinary autovaccines and In vitro tests for drug research. The company was founded in 2005 and is headquartered in Lodz, Poland. | Direttore/Membro del Consiglio | - |
MEDICALGORITHMICS S.A. | Direttore/Membro del Consiglio | - |
Formazione di Marcin Hoffmann
Georgia State University | Masters Business Admin |
Adam Mickiewicz University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MEDICALGORITHMICS S.A. | Health Technology |
Aziende private | 4 |
---|---|
Instytut Bioinfobank Sp zoo | |
BIB Seed Capital Management
BIB Seed Capital Management Investment ManagersFinance BIB Seed Capital Management (BIB Seed Capital) is the venture capital subsidiary of Instytut Bioinfobank Sp zoo. The firm was founded in 2007, and is headquartered in Poznan, Poland. | Finance |
Genovum Sp zoo
Genovum Sp zoo BiotechnologyHealth Technology Genovum Sp zoo provides biological data processing services. It offers services to the frontier industries: information technology, biotechnology, and health care. Its business involves the use of bioinformatics methods to support the sequencing of genomes, development of new enzymes, and new simple organisms with medicinal properties. Genovum was founded in August 2008 and is headquartered in Warschaw, Poland | Health Technology |
Proteon Pharmaceuticals SA
Proteon Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Proteon Pharmaceuticals SA develops, manufactures, and sells pharmaceutical products and drugs. The firm offers Bafasal and Bafador. Its services include Veterinary autovaccines and In vitro tests for drug research. The company was founded in 2005 and is headquartered in Lodz, Poland. | Health Technology |
- Borsa valori
- Insiders
- Marcin Hoffmann